Innovation backed by scientific evidence
Setting new gold standards in neurodegenerative disorder assessment
Indivi is developing and validating user-friendly, reliable, and responsive measurement instruments spanning across all key concepts of interest (COI), focusing on Multiple Sclerosis, Parkinson's disease, Alzheimer’s disease, and related dementias.
A Unique Quality Control Embedded in the Data Science Pipeline
By bringing together Konectomᵀᴹ and dreaMSᴹᴰ, Indivi is able to offer a best-in-class digital measurement technology solution in Multiple Sclerosis, and Parkinson's disease, while developing innovative solutions for Alzheimer’s disease and related dementias.
A Unique Quality Control Embedded in the Data Science Pipeline
By bringing together Konectomᵀᴹ and dreaMSᴹᴰ, Indivi is able to offer a best-in-class digital measurement technology solution in Multiple Sclerosis, and Parkinson's disease, while developing innovative solutions for Alzheimer’s disease and related dementias.
A Unique Quality Control Embedded in the Data Science Pipeline
By bringing together Konectomᵀᴹ and dreaMSᴹᴰ, Indivi is able to offer a best-in-class digital measurement technology solution in Multiple Sclerosis, and Parkinson's disease, while developing innovative solutions for Alzheimer’s disease and related dementias.
Konectom
Indivi
Your end-to-end scientific research partner in advancing digital endpoints
Indivi is developing and validating user-friendly, reliable, and responsive instruments, spanning across key measurement concepts of interest (COI). By bringing together Konectomᵀᴹ (licensed from Biogen) and dreaMSᴹᴰ technologies, Indivi’s platform now includes bespoke instruments for additional COIs such as voice, keystroke dynamics and bradykinesia.
Indivi is developing and validating user-friendly, reliable, and responsive measurement instruments, spanning across key concepts of interest (COI). By bringing together Konectomᵀᴹ (licensed from Biogen) and dreaMSᴹᴰ technologies, Indivi’s platform now includes bespoke instruments for additional COIs such as voice, keystroke dynamics and bradykinesia.
Indivi is developing and validating user-friendly, reliable, and responsive measurement instruments, spanning across key concepts of interest (COI). By bringing together Konectomᵀᴹ (licensed from Biogen) and dreaMSᴹᴰ technologies, Indivi’s platform now includes bespoke instruments for additional COIs such as voice, keystroke dynamics and bradykinesia.
Movement
Cognition
Vision
Balance
Dexterity
Voice
Movement
Cognition
Vision
Balance
Dexterity
Voice
Movement
Cognition
Vision
Balance
Dexterity
Voice
Clinical trial platform for neurology
Indivi
App
One single data capture system combining assessments
from multiple partner devices and Apps.
Indivi
Cloud
Real time data transfer to our secured cloud,
with automated data integrity and quality checks
Indivi
PRO
Advanced clinical trial platform
for pharma industry, clinical research
organisations, and academia
Pioneering the future of precision neurology
Indivi and RC2NB are dedicated to unlocking the immense potential of digital measurements in drug development.
Indivi’s close research cooperation with the teams at RC2NB (Co-CEOs Profs. Cristina Granziera and Ludwig Kappos) creates a unique intersection between expert knowledge in Software Development, Data Science, Clinical Science and Advanced Analytics (including Machine Learning and Artificial Intelligence).
The Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB) is an internationally renowned institution embedded in Basel University Hospital and University of Basel.
RC2NB specialises in the development and integration of innovative tools that comprehensively characterise the disease process, thus facilitating the development of better treatments and enabling personalised disease management for people affected by MS and other neuroimmune and neurodegenerative diseases.
Pioneering the future of precision neurology
Indivi and RC2NB are dedicated to unlocking the immense potential of digital measurements in drug development.
Indivi’s close research cooperation with the teams at RC2NB (Co-CEOs Profs. Cristina Granziera and Ludwig Kappos) creates a unique intersection between expert knowledge in Software Development, Data Science, Clinical Science and Advanced Analytics (including Machine Learning and Artificial Intelligence).
The Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB) is an internationally renowned institution embedded in Basel University Hospital and University of Basel.
RC2NB specialises in the development and integration of innovative tools that comprehensively characterise the disease process, thus facilitating the development of better treatments and enabling personalised disease management for people affected by MS and other neuroimmune and neurodegenerative diseases.
Pioneering the future of precision neurology
Indivi and RC2NB are dedicated to unlocking the immense potential of digital measurements in drug development.
Indivi’s close research cooperation with the teams at RC2NB (Co-CEOs Profs. Cristina Granziera and Ludwig Kappos) creates a unique intersection between expert knowledge in Software Development, Data Science, Clinical Science and Advanced Analytics (including Machine Learning and Artificial Intelligence).
The Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB) is an internationally renowned institution embedded in Basel University Hospital and University of Basel.
RC2NB specialises in the development and integration of innovative tools that comprehensively characterise the disease process, thus facilitating the development of better treatments and enabling personalised disease management for people affected by MS and other neuroimmune and neurodegenerative diseases.